This article is more than 5 years old. Information may no longer be current.
The Wistar Institute appoints associate professor
The Wistar Institute appointed Daniel W. Kulp, PhD, as associate professor in its vaccine center and translational tumor immunology program.
Kulp’s research focuses on how to use computer-designed vaccines to engineer protective immune responses against emerging and harmful infectious diseases.
His goal is to create vaccines and engineered antibody therapies that will eradicate infectious diseases related to HIV and arenaviruses. His computational and engineering expertise will allow him to translate his work for the development of innovative cancer therapeutics.
“I am thrilled to welcome Dan to The Wistar Institute and specifically our vaccine center,” Dario C. Altieri, MD, Wistar president and CEO, director of the cancer center, and the Robert and Penny Fox distinguished professor at The Wistar Institute, said in a press release. “His computational and directed engineering methods will be integral to the highly collaborative and transformational Wistar vaccine research community and scientific enterprise as a whole.”
Kulp has more than 15 years of experience developing molecular design software and leading protein engineering projects. He previously served as principal scientist at The Scripps Research Institute and International AIDS Vaccine Initiative.
“Wistar has a rich history of inventing vaccines and therapeutics, and its vaccine center continues to be a leader in vaccine research and development, including many efforts on HIV,” Kulp said. “My lab will focus on generating antibody-based vaccines and engineering new antibodies to address the need for therapies against a litany of disease targets such as arenaviruses, HIV and cancer.”